134 related articles for article (PubMed ID: 8657198)
1. Anti-mutagenic agents are also co-recombinogenic and can be converted into co-mutagens.
Fahrig R
Mutat Res; 1996 Feb; 350(1):59-67. PubMed ID: 8657198
[TBL] [Abstract][Full Text] [Related]
2. Anti-recombinogenic and convertible co-mutagenic effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted pyrimidine nucleoside analogs in S. cerevisiae MP1.
Fahrig R
Mutat Res; 1996 Nov; 372(1):133-9. PubMed ID: 9003540
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters.
Apostolides Z; Balentine DA; Harbowy ME; Hara Y; Weisburger JH
Mutat Res; 1997 Mar; 389(2-3):167-72. PubMed ID: 9093380
[TBL] [Abstract][Full Text] [Related]
4. Anti-mutagenic agents are also co-recombinogenic and co-mutagenic agents are also anti-recombinogenic.
Fahrig R
Mutat Res; 1995 Feb; 326(2):245-6. PubMed ID: 7529890
[No Abstract] [Full Text] [Related]
5. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene].
Pavlov IuI; Khromov-Borisov NN
Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182
[TBL] [Abstract][Full Text] [Related]
6. Diaminotoluenes induce intrachromosomal recombination and free radicals in Saccharomyces cerevisiae.
Brennan RJ; Schiestl RH
Mutat Res; 1997 Nov; 381(2):251-8. PubMed ID: 9434881
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
[TBL] [Abstract][Full Text] [Related]
8. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
Amacher DE; Turner GN
Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
[TBL] [Abstract][Full Text] [Related]
9. Activation of phenanthrene to mutagenic metabolites and evidence for at least two different activation pathways.
Oesch F; Bücker M; Glatt HR
Mutat Res; 1981 Mar; 81(1):1-10. PubMed ID: 7019683
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
[TBL] [Abstract][Full Text] [Related]
11. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
12. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
13. Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man.
Mori Y; Konishi Y
IARC Sci Publ; 1991; (105):398-403. PubMed ID: 1855888
[TBL] [Abstract][Full Text] [Related]
14. Co-recombinogenic and anti-mutagenic effects of diethylhexylphthalate, inactiveness of pentachlorophenol in the spot test with mice.
Fahrig R; Steinkamp-Zucht A
Mutat Res; 1996 Jul; 354(1):59-67. PubMed ID: 8692207
[TBL] [Abstract][Full Text] [Related]
15. Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens.
Gasiorowski K; Szyba K; Urban J
Mutat Res; 1994 Jul; 324(3):133-7. PubMed ID: 7517512
[TBL] [Abstract][Full Text] [Related]
16. Janus carcinogens and mutagens.
von Borstel RC; Higgins JA
Mutat Res; 1998 Jun; 402(1-2):321-9. PubMed ID: 9675327
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the mutagenic activation of N-nitrosopropylamines by various animal species and man: evidence for a cytochrome P-450 dependent reaction.
Yamazaki H; Mori Y; Toyoshi K; Nagai H; Koda A; Konishi Y
Jpn J Cancer Res; 1986 Feb; 77(2):107-17. PubMed ID: 3082822
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mutagenic and recombinogenic effects of some adenine analogues in Saccharomyces cerevisiae D7.
Sorenson WG; Simpson JP; Ong TM
Mutat Res; 1981 Jun; 82(1):95-100. PubMed ID: 7022174
[TBL] [Abstract][Full Text] [Related]
19. High mutagenic potency of several polycyclic aromatic hydrocarbons induced by liver postmitochondrial fractions from control and xenobiotic-treated immature carp.
Protić-Sabljić M; Kurelec B
Mutat Res; 1983 Aug; 118(3):177-89. PubMed ID: 6348528
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
Abu-Shakra A; Ioannides C; Walker R
Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
